<DOC>
	<DOCNO>NCT02930226</DOCNO>
	<brief_summary>Assess safety single infusion RePlas FDP product increase fixed dos</brief_summary>
	<brief_title>Ascending Doses Autologous FDP v FFP</brief_title>
	<detailed_description>This single-site , single-blind study healthy volunteer design assess safety infuse ascend dos reconstitute autologous FDP 3 fixed-dose cohort . Subjects Cohort 1 receive 1 unit FDP , approximately 270 mL . Subjects Cohort 2 receive 2 FDP unit , total approximately 540 mL . Cohorts 1 2 lower-dose cohort . Subjects assign begin low dose , Cohort 1 . In absence SAEs implementation protocol stopping rule ( SRs ) , subject assign Cohort 2 , dose increase 2 unit . For cohort subject also assign 1 2 single infusion treatment arm .</detailed_description>
	<criteria>Males nonpregnant/nonbreastfeeding female ; Minimum weight 140 pound , maximum weight 220 pound ; Ages 1855 year ; Selfreports feel well healthy ; Scores ≥ 35 Duke Activity Status Index ; Able donate 1 unit WB base AABB donor history questionnaire modification indicate . Subjects history travel put risk CreutzfeldtJakob Disease ( CJD ) malaria eligible participate ; Has read educational material donate blood question answer ; Able willing provide write informed consent ; Available duration trial , approximately 12 week subject Cohort 1 Cohort 2 , Arm 4 ; approximately 16 week Cohort 2 , Arm 3 Cohort 3 ( include time collection , product manufacture , infusion ) , able come treatment clinic schedule study visit ; Females childbearing potential either surgically sterile ( hysterectomy tubal ligation ) , use highly effective , medically accept contraceptive regimen . Highly effective method birth control define result lower failure rate ( i.e. , less 1 % per year ) use consistently correctly implant , injectables , combine oral contraceptive , intrauterine device , sexual abstinence , vasectomized partner ; All female must negative urine pregnancy test prior enrollment ; Understands English language . Known liver , kidney , cardiovascular , neurologic , gastrointestinal , blood , endocrine/metabolic , autoimmune pulmonary disease , treat untreated hypertension ; Cancer kind , treatment resolve ; Known past coagulopathy condition ; Any condition , medication , etc . AABB medical deferral list ; Past history asthma ( define use prescribed daily asthma controller medication require asthma medication past 2 week ) ; Past diagnosis stroke , deep vein thrombosis , transient ischemic attack Family history venous arterial thrombosis age 50 firstdegree relative ( i.e. , biological parent , full sibling , child ) ; History abnormal electrocardiogram ( EKG ) ; Current smoker ( define smoke within last 6 month ) ; Known Human Immunodeficiency Virus ( HIV ) Acquired Immunodeficiency Syndrome ( AIDS ) relate illness receive positive test result HIV infection ; Positive test Hepatitis B Virus ( HBV ) Hepatitis C Virus ( HCV ) Human Tcell Lymphotropic Virus ( HTLV ) ; History significant treat untreated mental health issue ; Female subject pregnant , lactating , positive pregnancy test ; Currently take antibiotic another medication infection ; Treatment use aspirin ( platelet inhibit agent ) within 14 day study donation infusion visit ; Currently use medication anticoagulant therapy ; Previous use clot factor concentrate ( ) ; Receipt blood blood product within past 12 month ; In past week , headache fever time ; Known intolerance excipients ( citrate ) study drug formulation ; Systolic blood pressure great 140 mmHg ; Diastolic blood pressure great 90 mmHg ; Temperature great 100°F ; Known hematocrit less 38 % male female donor ; Positive direct antiglobulin test ( DAT ) ; Treatment investigational agent within 1 month treatment infusion trial ; Participation phase investigational trial participate trial ; Unwilling unable comply requirement protocol , include presence condition ( physical , mental , social ) likely affect subject 's return followup visit schedule ; Other unspecified reason , opinion PI , make subject unsuitable enrollment ; Institutionalized legal regulatory order .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>